USPTO serial 79065741
TREERLY
Reviewed by CopyMark Law Group
Reg. 3754883Status 404
- Filing date
- Status date
- Registration date
- Mar 2, 2010
- Examiner
- HOFFMAN, DAVID AARON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TREERLY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michele A. Farber
Michele A. Farber Pfizer Inc.235 East 42nd StreetNew York, NY 10017UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; pharmaceutical preparations for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; raw material drugs for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; active pharmaceutical ingredients for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; biochemical drugs for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; biopharmaceuticals for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; dietetic food preparations adapted for medical purposes, namely, Omega-3,vitamins and minerals, herbal extracts; dietetic substances adapted for medical use, namely, Omega-3,vitamins and minerals, herbal extracts; nutritional additives to foodstuffs for medical purposes; injectable solution for medical use for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; solvents for medical use for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; medical drug tablets for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIORIO (CHINA) PHARM CO., LTD.
- Other trademarks owned by BIORIO (CHINA) PHARM CO., LTD.
- Other trademarks owned by TREERLY HEALTH CO., LTD.
- Other trademarks in Class 005
- Similar marks named TREERLY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 8, 2019 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Mar 8, 2019 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 15, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 17, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 14, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 20, 2017 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 20, 2017 | INPC | INVALIDATION PROCESSED | — |
| Jun 7, 2017 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 7, 2016 | C71T | CANCELLED SECTION 71 | — |
| Jul 20, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 20, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 2, 2015 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 6, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 26, 2012 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 18, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 18, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 2, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 2, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 15, 2009 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 15, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 10, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 5, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 22, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 22, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 21, 2009 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 21, 2009 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 21, 2009 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 21, 2009 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 27, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 27, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 27, 2009 | ALIE | ASSIGNED TO LIE | — |
| Aug 13, 2009 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 13, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 30, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 30, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 17, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 30, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 30, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 28, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 27, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 20, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 20, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 19, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |